Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 227-033-5 | CAS number: 5613-46-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- April - May 2012
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 012
- Report date:
- 2012
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- other: ICH S2B
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- 4,4'-isopropylidenedi-2,6-xylol
- EC Number:
- 227-033-5
- EC Name:
- 4,4'-isopropylidenedi-2,6-xylol
- Cas Number:
- 5613-46-7
- Molecular formula:
- C19H24O2
- IUPAC Name:
- 4,4'-isopropylidenedi-2,6-xylol
- Test material form:
- solid: particulate/powder
- Details on test material:
- - Purity: 99.74%
- Synonym: 4,4’-(1-methylethylidene)-bis(2,6-dimethylphenol)
Constituent 1
Method
Species / strainopen allclose all
- Species / strain / cell type:
- E. coli WP2 uvr A
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Metabolic activation:
- with and without
- Metabolic activation system:
- Aroclor 1254-induced rat liver S9
- Test concentrations with justification for top dose:
- 1.5, 5.0, 15, 50, 150, 500, 1500 and 5000 micrograms per plate with and w/out S9 activation (Preliminary toxicity and initial mutagenicity assay) – Plate incorporation method
2.0, 6.0, 20, 60, 200 and 600 micrograms per plate with all Salmonella tester strains and
60, 200, 600, 1800 and 5000 micrograms per plate with tester strain WP2 uvrA. (Independent repeat/confirmatory mutagenicity assay) – Plate incorporation method. Due to toxicity profiles that differed from that observed in the initial assay, tester strain TA100 in the absence of S9 activation and tester strain TA1537 in the presence of S9 activation were retested with an adjustment in dose levels: 0.15, 0.50, 1.5, 5.0, 15, 50, 150, 500, 1500 and 5000 micrograms per plate. - Vehicle / solvent:
- DMSO (CAS No. 67-68-5); from EMD Chemicals Incorporated
Controls
- Negative solvent / vehicle controls:
- yes
- Positive controls:
- yes
- Positive control substance:
- 9-aminoacridine
- 2-nitrofluorene
- sodium azide
- methylmethanesulfonate
- other: 2-aminoanthracene
- Details on test system and experimental conditions:
- Preliminary Toxicity/Initial Mutagenicity Assay: The preliminary toxicity/initial mutagenicity assay was used to establish the dose range over which the test article would be assayed and to provide a preliminary mutagenicity evaluation. A vehicle control, positive controls and eight dose levels of the test article were plated, two plates per dose, with overnight cultures of TA98, TA100, TA1535, TA1537 and WP2 uvrA on selective minimal agar in the presence and absence of Aroclor induced rat liver S9.
Confirmatory Mutagenicity Assay: The confirmatory mutagenicity assay was used to evaluate and confirm the mutagenic potential of the test article. Six to 10 dose levels of test article along with vehicle control and appropriate positive controls were plated with overnight cultures of TA98, TA100, TA1535, TA1537 and WP2 uvrA in the presence and absence of Aroclor induced rat liver S9. All dose levels of test article, vehicle control and positive controls were plated in triplicate.
Plating and Scoring Procedures: The test system was exposed to the test article via the plate incorporation method. On the day of its use, minimal top agar was melted and supplemented. Top agar, not used with S9 or Sham mix, was supplemented with 25 mL of water for each 100 mL of minimal top agar. For the preparation of media and reagents, all references to water imply sterile, deionized water. Bottom agar was supplemented Vogel Bonner minimal medium E.
Each plate was labeled with a code system that identified the test article, test phase, dose level, tester strain and activation.
Test article dilutions were prepared immediately before use. One half (0.5) milliliter of S9 or Sham mix, 100 microL of tester strain and 50 microL of vehicle or test article dilution were added to 2.0 mL of molten selective top agar at 45+/-2°C. After vortexing, the mixture was overlaid onto the surface of 25 mL of minimal bottom agar. When plating the positive controls, the test article aliquot was replaced by a 50 microL aliquot of appropriate positive control. After the overlay had solidified, the plates were inverted and incubated for approximately 48 to 72 hours at 37+/-2°C. Plates that were not counted immediately following the incubation period were stored at 2 8°C until colony counting could be conducted.
The condition of the bacterial background lawn was evaluated for evidence of test article toxicity by using a dissecting microscope. Precipitate was evaluated by visual examination without magnification. Toxicity and degree of precipitation was scored relative to the vehicle control plate.
Revertant colonies for a given tester strain and activation condition, except for positive controls, were counted either entirely by automated colony counter or entirely by hand unless the plate exhibited toxicity. - Evaluation criteria:
- For each replicate plating, the mean and standard deviation of the number of revertants per plate were calculated and reported.
For the test article to be evaluated positive, it must cause a dose-related increase in the mean revertants per plate of at least one tester strain over a minimum of two increasing concentrations of test article. Data sets for tester strains TA1535 and TA1537 were judged positive if the increase in mean revertants at the peak of the dose response is equal to or greater than 3.0-times the mean vehicle control value. Data sets for tester strains TA98, TA100 and WP2 uvrA were judged positive if the increase in mean revertants at the peak of the dose response is equal to or greater than 2.0-times the mean vehicle control value.
Results and discussion
Test resultsopen allclose all
- Species / strain:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- Generally observed beginning at 150, 500 or 5000 microg/plate
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- Generally observed beginning at 150, 500 or 5000 microg/plate
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- Generally observed beginning at 60, 200, 500, 600, or 1500 microg/plate
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- Generally observed beginning at 60, 200, 500, 600, or 1500 microg/plate
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- In the initial mutagenicity assay no positive mutagenic responses were observed with any of the tester strains in either the presence or absence of S9 activation. Precipitate was observed beginning at 500 or 1500 microg/plate. Toxicity was observed beginning at 150, 500 or at 5000 microg/plate with all test conditions except tester strain WP2 uvrA in the absence of S9 activation. Based on the findings of the initial toxicity-mutation assay, the maximum doses plated in the confirmatory mutagenicity assay were 600 microg/plate with all Salmonella tester strains and 5000 microg/plate with tester strain WP2 uvrA.
For the Confirmatory Mutagenicity Assay, no positive mutagenic responses were observed with any of the tester strains in either the presence or absence of S9 activation. Precipitate was observed beginning at 600 microg/plate. Toxicity was observed beginning at 60, 200 or at 600 microg/plate with all Salmonella tester strains except TA1537 in the presence of activation. Due to toxicity profiles that differed from that observed in the initial assay, tester strains TA100 and TA1537 in the absence or presence of S9 activation, respectively, were retested with adjustments to the dose levels. In experiment B3, no positive mutagenic responses were observed in either TA100 or TA1537 in the absence or presence of S9 activation, respectively. Precipitate was observed beginning at 500 microg/plate and toxicity was observed beginning at 500 or 1500 microg/plate. - Remarks on result:
- other: Initial Mutagenicity Assay
Any other information on results incl. tables
Initial Mutagenicity Assay
Mean Number of Revertants Per Plate
Activation: None
Dose (microg/plate) |
TA98 |
TA100 |
TA1535 |
TA1537 |
WP2uvrA |
Vehicle (DSMO) |
13 ± 4 |
98 ± 6 |
6 ± 1 |
5 ± 1 |
22 ± 2 |
1.5 |
10 ± 2 |
93 ± 5 |
11 ± 1 |
7 ± 1 |
19 ± 5 |
5.0 |
11 ± 4 |
91 ± 13 |
7 ± 1 |
5 ± 1 |
21± 0 |
15 |
8 ± 1 |
95 ± 8 |
7 ± 3 |
6 ± 1 |
17 ± 6 |
50 |
9 ± 2 |
74 ±4 |
8 ± 4 |
4 ± 1 |
17 ± 3 |
150 |
0 ± 0 |
0 ± 0 |
6 ± 1 |
4 ± 1 |
15 ± 3 |
500 |
0 ± 0 P |
0 ± 0 P |
0 ± 0 P |
4 ± 1 P |
21 ± 12 |
1500 |
0 ± 0 P |
0 ± 0 P |
0 ± 0 P |
3 ± 0 P |
12 ± 0 P |
5000 |
0 ± 0 P |
0 ± 0 P |
0 ± 0 P |
2 ± 1 P |
19 ± 1 P |
Positive Control |
199 ± 33 |
511 ± 6 |
456 ± 28 |
365 ± 58 |
385 ± 8 |
P = precipitate observed
Initial Mutagenicity Assay
Mean Number of Revertants Per Plate
Activation: S9
Dose (microg/plate) |
TA98 |
TA100 |
TA1535 |
TA1537 |
WP2uvrA |
Vehicle (DSMO) |
13 ± 1 |
104 ± 8 |
9 ± 2 |
10 ± 1 |
38 ± 8 |
1.5 |
14 ± 9 |
99 ± 12 |
10 ± 2 |
8 ± 3 |
40 ± 1 |
5.0 |
12 ± 7 |
86 ± 9 |
8 ± 3 |
5 ± 1 |
33 ± 8 |
15 |
13 ± 2 |
72 ± 5 |
11 ± 2 |
5 ± 1 |
30 ± 6 |
50 |
15 ± 5 |
77 ± 16 |
7 ± 1 |
4 ± 1 |
28 ± 0 |
150 |
12 ± 1 |
91 ± 8 |
9 ± 0 |
4 ± 1 |
28 ± 1 |
500 |
0 ± 0 P |
0 ± 0 P |
0 ± 0 P |
5 ± 3 P |
27 ± 0 P |
1500 |
0 ± 0 P |
0 ± 0 P |
0 ± 0 P |
5 ± 4 P |
26 ± 8 P |
5000 |
0 ± 0 P |
0 ± 0 P |
0 ± 0 P |
3 ± 0 P |
11 ± 0 P |
Positive Control |
237 ± 18 |
590 ± 55 |
83 ± 14 |
47 ± 5 |
189 ± 13 |
P = precipitate observed
Confirmatory Mutagenicity Assay
Mean Number of Revertants Per Plate
Activation: None
Dose (microg/plate) |
TA98 |
TA100 |
TA1535 |
TA1537 |
Vehicle (DSMO) |
23 ± 9 |
139 ± 11 |
11 ± 3 |
5 ± 5 |
2 |
20 ± 6 |
65 ± 8 |
13 ± 1 |
6 ± 3 |
6 |
24 ± 5 |
79 ± 7 |
10 ± 5 |
2 ± 2 |
20 |
24 ± 4 |
87 ± 15 |
11 ± 3 |
4 ± 1 |
60 |
18 ± 3 |
62 ± 13 |
11 ± 3 |
4 ± 3 |
200 |
10 ± 3 |
72 ± 9 |
11 ± 5 |
7 ± 3 |
600 |
0 ± 0 P |
0 ± 0 P |
0 ± 0 P |
4 ± 1 P |
Positive Control |
305 ± 40 |
473 ± 34 |
629 ± 26 |
738 ± 53 |
P = precipitate observed
Dose (microg/plate) |
WP2uvrA |
Vehicle (DSMO) |
14 ± 5 |
60 |
10 ± 3 |
200 |
11 ± 2 |
600 |
12 ± 1 P |
1800 |
13 ± 3 P |
5000 |
9 ± 2 P |
Positive Control |
295 ± 22 |
P = precipitate observed
Repeat Confirmatory Mutagenicity Assay for TA100
Mean Number of Revertants Per Plate
Activation: None
Dose (microg/plate) |
TA100 |
Vehicle (DSMO) |
83 ± 3 |
0.15 |
79 ± 1 |
0.50 |
86 ± 10 |
1.5 |
85 ± 2 |
5.0 |
86 ± 9 |
15 |
83 ± 1 |
50 |
82 ± 4 |
150 |
82 ± 5 |
500 |
55 ± 5 P |
1500 |
51 ± 9 P |
5000 |
55 ± 3 P |
Positive Control |
573 ± 9 |
P = precipitate observed
Confirmatory Mutagenicity Assay
Mean Number of Revertants Per Plate
Activation: S9
Dose (microg/plate) |
TA98 |
TA100 |
TA1535 |
TA1537 |
Vehicle (DSMO) |
32 ± 9 |
137 ± 14 |
10 ± 2 |
7 ± 2 |
2 |
26 ± 8 |
121 ± 14 |
9 ± 5 |
6 ± 3 |
6 |
28 ± 5 |
121 ± 18 |
11 ± 2 |
5 ± 1 |
20 |
30 ± 3 |
132 ± 12 |
11 ± 2 |
7 ± 4 |
60 |
25 ± 2 |
126 ± 4 |
10 ± 5 |
7 ± 3 |
200 |
25 ± 6 |
134 ± 16 |
12 ± 5 |
5 ± 3 |
600 |
0 ± 0 P |
0 ± 0 P |
12 ± 3 P |
6 ± 2 P |
Positive Control |
577 ± 40 |
671 ± 159 |
94 ± 14 |
51 ± 14 |
P = precipitate observed
Dose (microg/plate) |
WP2uvrA |
Vehicle (DSMO) |
20 ± 3 |
60 |
19 ± 2 |
200 |
19 ± 1 |
600 |
16 ± 4 P |
1800 |
16 ± 5 P |
5000 |
12 ± 1 P |
Positive Control |
188 ± 10 |
P = precipitate observed
Repeat Confirmatory Mutagenicity Assay for TA1537
Mean Number of Revertants Per Plate
Activation: S9
Dose (microg/plate) |
TA1537 |
Vehicle (DSMO) |
11 ± 1 |
0.15 |
9 ± 3 |
0.50 |
9 ± 3 |
1.5 |
8 ± 3 |
5.0 |
9 ± 4 |
15 |
9 ± 4 |
50 |
7 ± 2 |
150 |
8 ± 2 |
500 |
7 ± 4 P |
1500 |
7 ± 3 P |
5000 |
4 ± 0 P |
Positive Control |
76 ± 13 |
P = precipitate observed
Applicant's summary and conclusion
- Conclusions:
- negative with metabolic activation
negative without metabolic activation
All criteria for a valid study were met. The results of the Bacterial Reverse Mutation Assay indicate that, under the conditions of this study, TMBPA did not cause a positive response with any of the tester strains in either the presence or absence of Aroclor induced rat liver S9.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.